Efficacy and Safety of VDS+SU in the Treatment of OAB-dry in Children

NARecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

December 26, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Overactive BladderPediatric Disorder
Interventions
DRUG

Solifenacin

The outpatient physician prescribed Solinaxine (up to 0.5mg daily) to the participant orally

DIETARY_SUPPLEMENT

vitamin D

The outpatient physician prescribed vitamin d drops (2400iu daily) for the participants, which were taken orally by the participants

BEHAVIORAL

Standard behavioral therapy

Participants will receive an initial behavioral therapy session at enrollment and a second behavioral therapy session six weeks later. Education including information about dry OAB, lifestyle adjustments, bladder and pelvic floor training, bowel management, and how to use a bladder diary to record urination

Trial Locations (1)

400000

RECRUITING

Children's Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors
collaborator

Beijing Children's Hospital

OTHER

collaborator

Shanghai Children's Hospital

OTHER

collaborator

Children's Hospital of Soochow University

OTHER

collaborator

Guizhou Provincial People's Hospital

OTHER

lead

Xing Liu

OTHER